Causation, bias and confounding: A hitchhiker's guide to the epidemiological galaxy. Part 3: Principles of causality in epidemiological research: Statistical stability, dose- and duration-response effects, internal and external consistency, analogy and biological plausibility

Journal of Family Planning and Reproductive Health Care

Volumn 34, Issue 4, 2008, Pages 261-264

  Shapiro, Samuel ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ORAL CONTRACEPTIVE AGENT; PHENYLPROPANOLAMINE; RESERPINE;

BREAST CANCER; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; DOSE RESPONSE; ENDOMETRIUM CANCER; EPIDEMIOLOGY; HEART INFARCTION; HUMAN; INTERNAL CONSISTENCY; LUNG CANCER; MEDICAL RESEARCH; REVIEW; RISK FACTOR; SAMPLING ERROR; SMOKING; STATISTICAL ANALYSIS; UTERUS CANCER; VENOUS THROMBOEMBOLISM;

DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC FACTORS; HUMANS;

EID: 42249089293     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118908786000596     Document Type: Review

References (17)

1. Shapiro S. Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 1. Principles of causality in epidemiological research: time order, specification of the study base and specificity. J Fam Plan Reprod Health Care 2008; 34: 83-87.
2. Shapiro S. Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 2. Principles of causality in epidemiological research: confounding, effect modification and strength of association. J Fam Plan Reprod Health Care 2008; 34: 185-190.
3. Kernan WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000; 343: 1826-1832.
4. Boston Collaborative Drug Surveillance Program. Reserpine and breast cancer. Lancet 1974; ii: 669-671.
5. Shapiro S. Meta-analysis/shmeta-analysis. Am J Epidemiol 1994; 140: 771-778.
6. Shapiro S, Parsells JL, Rosenberg L, Kaufman DW, Stolley PD, Schottenfeld D. Risk of breast cancer in relation to the use of rauwolfia alkaloids. Eur J Clin Pharmacol 1984; 26: 143-146.
7. Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L. First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception 1997; 56: 141-146.
8. Suissa S, Spitzer WO. Oral contraceptives and the risk of venous thromboembolism: impact of duration of use. Contraception 1998; 57: 64-68.
9. Suissa S, Spitzer WO, Rainville B, Cusson J, Lewis M, Heinemann L. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod 2000; 15: 817-821.
10. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy (8th edn) Littleton, MA: Publishing Sciences Group, 1977.
11. Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogens and endometrial carcinoma. N Engl J Med 1975; 293: 1164-1167.
12. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293: 1167-1170.
13. Horwitz RI, Feinstein AR. Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med 1978; 299: 1089-1094.
14. Shapiro S, Kaufman DW, Slone D, Rosenberg L, Miettinen OS, Stolley PD, et al. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium. N Engl J Med 1980; 303: 485-489.
15. International Agency for Research on Cancer (IARC). Hormonal Contraception and Post-Menopausal Hormone Therapy (IARC Monographs on the Evaluation of Carcinogenic Risk to Humans Vol. 72). Lyon, France: IARC, 1999.
16. International Agency for Research on Cancer (IARC). Combined Oestrogen-Progestin Contraceptives and Combined Oestrogen-Progestin Menopausal Therapy (IARC Monographs on the Evaluation of Carcinogenic Risk to Humans Vol. 91). Lyon, France: IARC, 2008. http://monographs.iarc.fr/ENG/recentpub/mono91.pdf [Accessed 4 February 2008] OR IARC 1989?
17. Shapiro S. Looking to the 21st century: have we learned from our mistakes, or are we doomed to compound them? Pharmacoepidemiol Drug Saf 2004; 13: 257-265.